Drug application
PAGITANE (CYCRIMINE HYDROCHLORIDE)
Drugs@FDA NDA 008951 · LILLY
Key facts
| Drug name | PAGITANE |
|---|---|
| Active ingredients | CYCRIMINE HYDROCHLORIDE |
| Application type | NDA |
| Application number | 008951 |
| Company | LILLY |
| Dosage forms | TABLET, ORAL |
| Strength | 1.25MG |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission class | Type 1 - New Molecular Entity |
| Latest submission status date | Jul 22, 1953 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.